Volver a Agenda
Session 6: Patient Contributed Data
Session Chair(s)
Marni Hall, PHD, MPH
Vice President and General Manager, Global Regulatory Science and Strategy , IQVIA, United States
This session will focus on patient-generated health data (PGHD). Different types of PGHD, such as structured and unstructured forms, and criteria for their use will be discussed. Case studies of assessment and application of use of PGHD for clinical and regulatory decision-making will be shared. Concrete steps for advancing greater use of PGHD will be outlined
Learning Objective : At the conclusion of this session, participants should be able to:- Describe different types of PGHD
- Formulate evaluation method(s) to validate use of PGHD for a specific purpose
- Identify opportunities for pilot projects to advance the use of PGHD
Speaker(s)
23andMe: Innovation in Clinical Trial Recruitment
Vice President of Business Development, 23andMe, United States
Patient Contributed Data
Co-Founder & President, Evidation Heath, Inc., United States
Patient Contributed Data
Executive Director, Clinical Trials Transformation Initiative (CTTI), United States
¿Tiene una cuenta?